Mobile acute stroke units: bringing the hospital to the patient.

摘要

It is well established that the benefits of thrombolysis for acute ischaemic stroke decline with delay from stroke onset to treatment. Furthermore, there is little evidence from studies in hospital settings to suggest that the risk of adverse effects of thrombolysis is greater in appropriately selected patients treated early within the accepted time window. Substantial effort is therefore put into designing acute stroke pathways in such a way that the delay from hospital admission to thrombolysis, the so-called door-to-needle time, is minimised.